Crestor 5 mg tabletti, kalvopäällysteinen फ़िनलैंड - फ़िनिश - Fimea (Suomen lääkevirasto)

crestor 5 mg tabletti, kalvopäällysteinen

astrazeneca oy - rosuvastatin calcium - tabletti, kalvopäällysteinen - 5 mg - rosuvastatiini

Seroquel Prolong 50 mg depottabletti फ़िनलैंड - फ़िनिश - Fimea (Suomen lääkevirasto)

seroquel prolong 50 mg depottabletti

astrazeneca oy - quetiapine fumarate - depottabletti - 50 mg - ketiapiini

Seroquel Prolong 200 mg depottabletti फ़िनलैंड - फ़िनिश - Fimea (Suomen lääkevirasto)

seroquel prolong 200 mg depottabletti

astrazeneca oy - quetiapine fumarate - depottabletti - 200 mg - ketiapiini

Seroquel Prolong 300 mg depottabletti फ़िनलैंड - फ़िनिश - Fimea (Suomen lääkevirasto)

seroquel prolong 300 mg depottabletti

astrazeneca oy - quetiapine fumarate - depottabletti - 300 mg - ketiapiini

Seroquel Prolong 400 mg depottabletti फ़िनलैंड - फ़िनिश - Fimea (Suomen lääkevirasto)

seroquel prolong 400 mg depottabletti

astrazeneca oy - quetiapine fumarate - depottabletti - 400 mg - ketiapiini

Seroquel Prolong 150 mg depottabletti फ़िनलैंड - फ़िनिश - Fimea (Suomen lääkevirasto)

seroquel prolong 150 mg depottabletti

astrazeneca oy - quetiapine fumarate - depottabletti - 150 mg - ketiapiini

Symbicort 160 mikrog / 4.5 mikrog / inhalaatio inhalaatiosumute, suspensio फ़िनलैंड - फ़िनिश - Fimea (Suomen lääkevirasto)

symbicort 160 mikrog / 4.5 mikrog / inhalaatio inhalaatiosumute, suspensio

astrazeneca oy - budesonide, formoterol fumarate dihydrate - inhalaatiosumute, suspensio - 160 mikrog / 4.5 mikrog / inhalaatio - formoteroli ja budesonidi

Fasenra यूरोपीय संघ - फ़िनिश - EMA (European Medicines Agency)

fasenra

astrazeneca ab - benralizumab - astma - obstruktiivisten hengitystiesairauksien lääkkeet, - fasenra on merkitty add huolto hoito aikuisilla potilailla, joilla on vaikea eosinofiilinen astma on riittävästi hallinnassa huolimatta korkea-annos inhaloitavat kortikosteroidit plus pitkävaikutteista β-agonistit.

Lokelma यूरोपीय संघ - फ़िनिश - EMA (European Medicines Agency)

lokelma

astrazeneca ab - natrium zirkonium cyclosilicate - hyperkalemia - kaikki muut terapeuttiset tuotteet - lokelma on tarkoitettu hoitoon hyperkalemia aikuisilla potilailla.

Imfinzi यूरोपीय संघ - फ़िनिश - EMA (European Medicines Agency)

imfinzi

astrazeneca ab - durvalumab - karsinooma, ei-pienisoluinen keuhko - antineoplastiset aineet - non-small cell lung cancer (nsclc)imfinzi as monotherapy is indicated for the treatment of locally advanced, unresectable non small cell lung cancer (nsclc) in adults whose tumours express pd-l1 on ≥ 1% of tumour cells and whose disease has not progressed following platinum based chemoradiation therapy (see section 5. imfinzi in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic nsclc with no sensitising egfr mutations or alk positive mutations. small cell lung cancer (sclc)imfinzi in combination with etoposide and either carboplatin or cisplatin is indicated for the first-line treatment of adults with extensive-stage small cell lung cancer (es-sclc). biliary tract cancer (btc)imfinzi in combination with gemcitabine and cisplatin is indicated for the first line treatment of adults with unresectable or metastatic biliary tract cancer (btc). hepatocellular carcinoma (hcc)imfinzi in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc).